Replies to post #145586 on OWC Pharmaceutical Research Corp (OWCP)

[zombywolf]

Problem is that it is difficult to value no revenue, and none for the forseeable future. Would be different if some of their patent apps were awarded patents (man, some of those apps have to be 3 yrs old by now). Patents have value, products have value, assets have value. We dont have any of that. Research is great, but it is a negative drain without corresponding revenue. So we dive on no news, and we rise on rumor.

[zioni007]

Come october I think we will be there, once we get results from IRB and clinical info,

[I-Glow]

Please back up your valuation with facts - what model did you use for the valuation?

From the Balance sheet etc the OWCP valuation would be a trips stock.

There isn't any assets - there isn't any revenue - there isn't any IP (patents) - there isn't any proof that OWCP has completed any research or clinical trials - since 2014 OWCP hasn't published any research or clinical data. Then there is the missing efficacy report.

OWCP promises a great deal. But never delivers anything.

There isn't any real valuation that would put the price at 0.50 - complete nonsense.

IG